eBioMedicine

Article	Citations
Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?	366
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology	297
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity	240
Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression	214
Microplastics detected in cirrhotic liver tissue	212
Therapeutic targeting of “undruggable” MYC	188
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies	183
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection	180
Lactate in the tumour microenvironment: From immune modulation to therapy	174
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial	169
Intranasal COVID-19 vaccines: From bench to bed	161
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients	157
Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study	156
Attention is not all you need: the complicated case of ethically using large language models in healthcare and medicine	156
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion	155
Host genetic factors determining COVID-19 susceptibility and severity	151
Kidney damage causally affects the brain cortical structure: A Mendelian randomization study	142
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machi	139
Characterizing Long COVID: Deep Phenotype of a Complex Condition	139
Emerging SARS-CoV-2 variants expand species tropism to murines	133
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity	131
Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression	128
The gut virome: A new microbiome component in health and disease	126
Gut microbiota and its metabolites in depression: from pathogenesis to treatment	124
Circulating tumor cell isolation for cancer diagnosis and prognosis	123

Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series	121
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses	119
Machine learning for brain age prediction: Introduction to methods and clinical applications	114
Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up	112
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies	112
Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS	112
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies	112
Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice	111
Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies	108
Benchmarking large language models’ performances for myopia care: a comparative analysis of ChatGPT-3.5, ChatGPT-4.0, and Google Bard	104
Clinical tools and biomarkers to predict preeclampsia	104
The complex genetic architecture of Alzheimer's disease: novel insights and future directions	102
Epigenome-wide association study of COVID-19 severity with respiratory failure	99
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters	99
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model	98
Inflammation and resolution signaling in cardiac repair and heart failure	98
Klebsiella species: Taxonomy, hypervirulence and multidrug resistance	98
Deep-learning-assisted detection and segmentation of rib fractures from CT scans: Development and validation of FracNet	98
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong	97
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease	91
SARS-CoV-2 leads to a small vessel endotheliitis in the heart	90
MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer	90
MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis	89
Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures	89
Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer	87
Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin	86
Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy	85
Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer	85
Clinical features and prognostic factors in Covid-19: A prospective cohort study	84
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial	84
Decreased miR-214–3p activates NF-κB pathway and aggravates osteoarthritis progression	83
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern	81
Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice	81
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes	81
The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads	80
Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes	79
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate	79
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants	78
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence	77
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model	76
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis	76
Recent advances in the mechanisms and treatment of immune thrombocytopenia	74
Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection	74
Alterations of host-gut microbiome interactions in multiple sclerosis	74
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity	74
Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy	74
Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human	73
Pharmacological advances in mitochondrial therapy	72
A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19	72
Oral administration of maternal vaginal microbes at birth to restore gut microbiome development in infants born by caesarean section: A pilot randomised placebo-controlled trial	72

Immunopathophysiology of human sepsis	72
A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis	71
Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma	70
Senescent T cells: a potential biomarker and target for cancer therapy	70
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability	69
Newborn telomere length predicts later life telomere length: Tracking telomere length from birth to child- and adulthood	69
Gut microbiome in modulating immune checkpoint inhibitors	69
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial	69
Single cell RNA-seq analysis identifies ferroptotic chondrocyte cluster and reveals TRPV1 as an anti-ferroptotic target in osteoarthritis	68
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19	68
Developing RT-LAMP assays for rapid diagnosis of SARS-CoV-2 in saliva	67
Synovial tissue from sites of joint pain in knee osteoarthritis patients exhibits a differential phenotype with distinct fibroblast subsets	67
Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients	66
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination	66
Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy	66
Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract	65
Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy	64
Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR	64
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients	64
Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre study	64
Current and future nanoparticle vaccines for COVID-19	63
A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: A multicentre study	63
Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients	63
Novel targets, treatments, and advanced models for intracerebral haemorrhage	63
Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study	63
Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study	62
Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation	62
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications	61
Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses	61
CAR-macrophage: An extensive immune enhancer to fight cancer	61
Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis	61
A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases	61
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy	60
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer	60
Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes	59
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers	59
A novel CRISPR-based malaria diagnostic capable of Plasmodium detection, species differentiation, and drug-resistance genotyping	59
Algorithmic fairness in computational medicine	59
SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors	58
Long-term exposure to ambient air pollution is a risk factor for trajectory of cardiometabolic multimorbidity: A prospective study in the UK Biobank	57
Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model	56
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy	56
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers	55
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France	55
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection	55
Early-life gut microbiota and its connection to metabolic health in children: Perspective on ecological drivers and need for quantitative approach	54
Hypoxia and chronic kidney disease	54
The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation	54
Precision medicine advances in idiopathic pulmonary fibrosis	53
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection	53
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity	53
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint	53
Deep Learning for Classification of Bone Lesions on Routine MRI	53
Current sepsis therapeutics	53
Dysregulation of cholesterol homeostasis in human lung cancer tissue and tumour-associated macrophages	53
In vivo whole brain microvascular imaging in mice using transcranial 3D Ultrasound Localization Microscopy	52
Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance	52
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients	52
Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs	52
Deep learning-based classification of primary bone tumors on radiographs: A preliminary study	52
Maternal prenatal gut microbiota composition predicts child behaviour	51
Air pollution and risk of chronic obstructed pulmonary disease: The modifying effect of genetic susceptibility and lifestyle	51
Biliary Atresia – emerging diagnostic and therapy opportunities	51
Sepsis biomarkers and diagnostic tools with a focus on machine learning	51
The land-scape of immune response to monkeypox virus	50
Therapeutic strategies in ischemic cardiomyopathy: Focus on mitochondrial quality surveillance	50
Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies	50
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males	50
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis	49
DNA methylation-based biomarkers of age acceleration and all-cause death, myocardial infarction, stroke, and cancer in two cohorts: The NAS, and KORA F4	49
Challenges and achievements of liquid biopsy technologies employed in early breast cancer	49
A thermostable Cas12b from Brevibacillus leverages one-pot discrimination of SARS-CoV-2 variants of concern	48
LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy	48
A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens	48
Multiday cycles of heart rate are associated with seizure likelihood: An observational cohort study	48
A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways	47
Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis	47
Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities	47
The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data	46
Deep learning-based clustering robustly identified two classes of sepsis with both prognostic and predictive values	46

Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease	46
Accurate diagnosis and prognosis prediction of gastric cancer using deep learning on digital pathological images: A retrospective multicentre study	46
Integrated multi-omics reveal epigenomic disturbance of assisted reproductive technologies in human offspring	46
Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19	46
Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor	46
Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months	45
Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation	45
MRI radiomics-based machine learning classification of atypical cartilaginous tumour and grade II chondrosarcoma of long bones	45
Development and validation of a real-time artificial intelligence-assisted system for detecting early gastric cancer: A multicentre retrospective diagnostic study	45
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma	45
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis	44
Ensuring that biomedical AI benefits diverse populations	44
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro	44
The gut microbiome influences the bioavailability of olanzapine in rats	44
Impaired autophagy: The collateral damage of lysosomal storage disorders	43
Circulating exosomes and gut microbiome induced insulin resistance in mice exposed to intermittent hypoxia: Effects of physical activity	43
A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology	43
Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19	43
The COVID-19 pandemic as an opportunity for unravelling the causative association between respiratory viruses and pneumococcus-associated disease in young children: a prospective study	43
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET	43
Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma	43
CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas	43
Vitamin B12 and gut-brain homeostasis in the pathophysiology of ischemic stroke	42
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2	42
Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2	42
Alterations of the gut mycobiome in patients with MS	42
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals	42
Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm	42
Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers	42
A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach	42
Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade	41
Cardiorenal protection of SGLT2 inhibitors—Perspectives from metabolic reprogramming	41
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients	41
Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis	41
Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction	41
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics	41
ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner	40
Brain cell-derived exosomes in plasma serve as neurodegeneration biomarkers in male cynomolgus monkeys self-administrating oxycodone	40
Cellular and molecular biomarkers of long COVID: a scoping review	40
Unraveling the complex interplay between genes, environment, and climate in ALS	40
Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?	40
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans	40
Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses	40
New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials	39
Maternal fecal microbiome predicts gestational age, birth weight and neonatal growth in rural Zimbabwe.	39
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2	39
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis	39
Association between plasma proteome and childhood neurodevelopmental disorders: A two-sample Mendelian randomization analysis	39
Ageing with HIV: Challenges and biomarkers	39
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection	39
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis	39
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study	39
Patient engagement in preclinical laboratory research: A scoping review	38
Mesenchymal stem cell treatment for COVID-19	38
Using graph convolutional network to characterize individuals with major depressive disorder across multiple imaging sites	38
Mind the gap – Managing tuberculosis across the disease spectrum	38
Gut microbiota in the pathogenesis and therapeutic approaches of diabetes	38
Predictors of survival in patients with amyotrophic lateral sclerosis: A large meta-analysis	38
Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target	38
Metagenomic next-generation sequencing to identify pathogens and cancer in lung biopsy tissue	38
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents	38
Canonical WNT pathway is activated in the airway epithelium in chronic obstructive pulmonary disease	38
Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank	38
Off balance: Interferons in COVID-19 lung infections	38
The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum	38
Deep learning features from diffusion tensor imaging improve glioma stratification and identify risk groups with distinct molecular pathway activities	37
Benzalkonium chloride antagonises aminoglycoside antibiotics and promotes evolution of resistance	37
Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT	37
Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models	37
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial	37
Identification of a wide spectrum of ciliary gene mutations in nonsyndromic biliary atresia patients implicates ciliary dysfunction as a novel disease mechanism	37
Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine	37
Near infrared photoimmunotherapy for cancers: A translational perspective	37
Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies	36
Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis	36
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-c	36
Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluation	36
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza	36
ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression	36
A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models	36
RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H	35
Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer	35
Towards equitable and trustworthy genomics research	35
Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals	35
A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI	35
Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis	35
A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests	35
Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial	34
A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy	34
Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies	34
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies	34
Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response	34
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis	34
Open pathways for cerebrospinal fluid outflow at the cribriform plate along the olfactory nerves	34
An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer	34